Position in DYN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,842,822
-$6,894,390 QoQ
Shares Held
929,003
-23.4% QoQ
Ownership
0.650%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 91.10271979746028.ToString("F0")%
Shared 0.ToString("F0")%
None 8.897280202539712.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. DYN ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in DYN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,842,822 | 929,003 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $23,737,212 | 1,213,559 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $17,950,434 | 1,419,007 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $12,967,912 | 1,362,176 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $14,555,997 | 1,391,587 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,754,648 | 753,593 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $37,833,167 | 1,053,262 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $19,728,940 | 559,052 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $27,315,832 | 962,164 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $26,884,551 | 2,021,395 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $965,364 | 107,742 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,292,004 | 114,845 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,309,014 | 113,630 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $746,740 | 64,430 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,645,154 | 129,540 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,566,699 | 228,050 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,935,793 | 304,543 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $4,445,907 | 373,920 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,685,351 | 103,778 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $97,960 | 4,656 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $1,956 | 126 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $509,775 | 24,275 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||